Lilly to test combinations with Merck, Bristol-Myers' cancer drugs

January 13, 2015 2:05 PM

3 0

(Reuters) - Eli Lilly & Co signed two separate deals with Merck & Co Inc and Bristol-Myers Squibb Co to test combinations of its cancer treatments with two recently approved therapies that belong to a promising new class of drugs.

Lilly will test its treatments - approved and experimental - in combination with PD-1 inhibitors Keytruda and Opdivo.

Also read: AT&T/Time Warner Merger a Sign of New Media Environment's Challenges

Read more

To category page